Aurobindo Pharma Gets FTC Approval For $250 Million Lannett Acquisition

Deal Strengthens US Manufacturing Presence And Expands Complex Generics Portfolio Aurobindo Pharma has received approval from the United States Federal Trade Commission (FTC) for its proposed acquisition of Lannett Company … Continue reading Aurobindo Pharma Gets FTC Approval For $250 Million Lannett Acquisition